(US) /    Tel: (781) 999-4286 / (857) 239-0968
Home > FGFR
Cat.No. Product Name Information Area
T4075 Sulfatinib Sulfatinib may be a potent drug for cancer. It inhibits KDR and FGFR1 enzymatic activ... Cancer
T3492 PD-166866 PD166866 is a selective FGFR tyrosine kinase inhibitor. Cancer
T3466 FIIN-3 FIIN-3 is an irreversible inhibitor of FGFR. Cancer
T3456 BLU-554 BLU-554 is a potent inhibitor of fibroblast growth factor receptor 4 (FGFR4). Cancer
T3726 Erdafitinib Erdafitinib is a quinoxaline derivative compound, acts on FGFR1/2/3/4. Cancer
T3714 SUN 11602 SUN11602, an aniline compound, mimics the neuroprotective mechanisms of basic fibrobl... Nervous system
T3274 S49076 S49076 is a novel, potent inhibitor of MET, AXL/MER, and FGFR1/2/3, blocking cellular... Cancer
T6996 SU5402 SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 ... Others
T6836 FIIN-2 FIIN-2, an irreversible, pan-FGFR inhibitor, inhibits FGFR1/2/3/4 with IC50 of 3.09 n... Others
T6124 Mubritinib (TAK 165)new Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2 with IC50 of 6 nM. Cancer
T6082 SSR128129E SSR128129E is an allosteric and orally-active FGFR1 inhibitor (IC50: 1.9 μM), but not... Cancer
T6024 CH5183284 (Debio-1347) CH5183284 is a selective and orally available FGFR inhibitor, which is for FGFR1(IC50... Cancer
T3074 CHIR98014 CHIR 98014 is a potent GSK-3α/β inhibitor with IC50 of 0.65 nM/0.58 nM in cell-free a... Cancer
T3068 AT9283 AT9283 is an effective multi-targeted inhibitor of JAK2(IC50=1.2 nM) and JAK3(IC50=1... Cancer
T2642 PD173074 PD173074 is an effective FGFR1 inhibitor (IC50: 25 nM) and also inhibits VEGFR2 (IC50... Cancer
T2638 Gandotinib (LY2784544) LY2784544(Gandotinib) is a potent JAK2 inhibitor (IC50: 3 nM), effective in JAK2V617F... Cancer
T2620 G-749 G-749, a new-type FLT3 inhibitor, exhibits effective and sustained inhibition of the ... Cardiovascular System
T2576 Brivanib alaninate Brivanib Alaninate is the alaninate salt of a vascular endothelial growth factor rece... Cancer
T2446 KI8751 KI8751 is a potent and selective inhibitor of VEGFR2 with IC50 of 0.9 nM. Cancer
T2372 Ponatinib Ponatinib is a tyrosine kinase receptor inhibitor that is used in the therapy of refr... Cardiovascular System
T2361 LY2874455 LY2874455 has been used in trials studying the treatment of Advanced Cancer. Cancer
T2347 BLU9931 BLU9931 is the first selective small molecule inhibitor of FGFR4. Cancer
T2215 Ferulic Acid Ferulic Acid is a highly abundant phenolic phytochemical and a type of organic compou... Immunology
T1975 BGJ398 (NVP-BGJ398) BGJ398 (NVP-BGJ398) is an orally bioavailable pan FGFR inhibitor for FGFR1/2/3 (IC50:... Other
T1948 AZD4547 AZD4547, a new-type specific FGFR inhibitor, targetes for FGFR1( IC50=0.2 nM)/FGFR2(I... Other
T1895 SKLB610 SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kin... Cancer
T1792 Regorafenib Regorafenib is a Kinase Inhibitor. The mechanism of action of regorafenib is as a Pro... Cancer
T1777 BIBF 1120 Nintedanib is an orally bioavailable, indolinone-derived, receptor tyrosine kinase (R... Other
T1639 Amlexanox Amlexanox is an anti-aphthous ulcer drug. Amlexanox inhibits the synthesis and releas... Respiratory system
T1537 Rapamycinhot Sirolimus is a macrolide compound obtained from Streptomyces hygroscopicus that acts ... Cancer